President Donald Trump’s threat of tariffs on pharmaceutical imports caused biopharma stocks and ETFs to dip after a brief surge. These tariffs would reintroduce costs for businesses that had enjoyed a pause as part of a 104% tariff tussle with China. The largest ETF, iShares Biotechnology ETF, dropped 0.3% in after-hours trading, while the fourth-largest, ARK Genomic Revolution ETF, gained 83% over the same period.
CISA extends CVE program contract for 11 months
The Department of Homeland Security has extended funding for the CVE Program, vital for cybersecurity and managed by MITRE. This program helps organizations manage vulnerabilities
.png?w=0&resize=0,0&ssl=1 "New Windows Task Scheduler Vulnerabilities Allows Command Execution as Admin User")
